BK viruria and viremia in children with systemic lupus erythematosus

Gupta, Nirupama; Nguyen, Cuong Q.; Modica, Renee F.; Elder, Melissa E.; Garin, Eduardo H.

doi:10.1186/s12969-017-0156-2

Pediatric Rheumatology

Table 2 BK viruria and/or viremia in all enrolled patients ^a

From: BK viruria and viremia in children with systemic lupus erythematosus

Patient	At enrollment		3 months		6 months		9 months		12 months
	Urine	Blood	Urine	Blood	Urine	Blood	Urine	Blood	Urine	Blood
1	Negative	Negative	Negative	Negative	Negative	*Positive* *15.6*	Negative	Negative	n/a	n/a
2	Negative	Negative	Negative	Negative	Negative	Negative	n/a	Negative	n/a	Negative
3	Negative	Negative	Negative	Negative	n/a	*Positive* *30.9*	Negative	Negative	Negative	Negative
4	Negative	Negative	Negative	Negative	*Positive* *0.03*	*Positive* *2.65*	Negative	Negative	Negative	Negative
^b 5	Negative	Negative	Negative	Negative	*Positive* *1.04×10* ⁴	*Positive* *0.68*	*Positive* *1.86×10* ⁴	Negative	*Positive* *1.76×10* ³	Negative
6	Negative	Negative	*Positive* *527*	Negative	Negative	*Positive* *4.5*	n/a	n/a	Negative	Negative
7	Negative	Negative	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
8	Negative	Negative	*Positive* *1.60*	Negative	Negative	Negative	n/a	n/a	Negative	Negative
^b 9	Negative	*Positive* *1.5x10* ⁶	Negative	Negative	Negative	*Positive* *4.3*	Negative	Negative	Negative	Negative
10	Negative	Negative	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
11	Negative	Negative	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
^b 12	Negative	Negative	n/a	Negative	n/a	n/a	n/a	n/a	n/a	n/a
^b 13	Negative	Negative	*Positive* *563*	n/a	Negative	Negative	n/a	n/a	n/a	n/a
^b 14	Negative	Negative	Negative	Negative	Negative	Negative	n/a	n/a	n/a	n/a
^c 15	Negative	Negative	n/a	n/a	n/a	n/a	Negative	Negative	n/a	n/a
16	Negative	Negative	n/a	n/a	n/a	n/a	n/a	n/a	Negative	Negative
17	Negative	Negative	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
18	Negative	Negative	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
^b 19	Negative	Negative	Negative	Negative	Negative	Negative	n/a	n/a	Negative	Negative
20	Negative	Negative	Negative	n/a	Negative	Negative	Negative	n/a	n/a	n/a
21	Negative	Negative	n/a	n/a	Negative	Negative	n/a	n/a	n/a	n/a
22	Negative	Negative	Negative	*Positive* *26.5*	Negative	Negative	Negative	Negative	n/a	n/a
^b 23	Negative	Negative	*Positive* *2.47*	*Positive* *2.84*	n/a	n/a	n/a	n/a	Negative	Negative
24	Negative	Negative	Negative	Negative	Negative	Negative	n/a	n/a	n/a	n/a
25	Negative	Negative	Negative	Negative	Negative	Negative	Negative	Negative	Negative	Negative
^c 26	*Positive* *0.07*	Negative	Negative	Negative	Negative	Negative	Negative	Negative	Negative	Negative
^c 27	Negative	*Positive* *33.5*	Negative	n/a	n/a	n/a	n/a	n/a	n/a	n/a
28	Negative	Negative	Negative	Negative	Negative	Negative	n/a	n/a	n/a	n/a
29	Negative	Negative	n/a	n/a	n/a	n/a	Negative	Negative	n/a	n/a
30	Negative	Negative	Negative	Negative	Negative	Negative	Negative	Negative	Negative	Negative
31	Negative	Negative	Negative	n/a	n/a	n/a	Negative	Negative	n/a	n/a
32	Negative	Negative	Negative	Negative	n/a	n/a	n/a	n/a	n/a	n/a
Positive BKV/Total Samples (%)	1/32 (3.1%)	2/32 (6.2%)	4/22 (18.1%)	2/19 (10.5%)	2/18 (11.1%)	6/19 (31.5%)	1/13 (7.6%)	0/13 (0%)	1/12 (8.3%)	0/13 (0%)

^a BKV copies/ml
^b MCTD
^c Overlap syndrome, n/a—not available
Bold italic indicates positive tests

Back to article page

ISSN: 1546-0096

Contact us

Submission enquiries: Access here and click Contact Us
General enquiries: info@biomedcentral.com